Early research (Phase 1)Study completedNCT04644120
What this trial is testing
Study to Assess Adverse Events and How Intravenous (IV) ABBV-47D11 and IV ABBV-2B04 Given Alone and in Combination Moves Through the Body of Adult Participants With Coronavirus Disease 2019 (COVID-19)
Who this might be right for
CoronaVirus Disease-2019 (COVID-19)
AbbVie 25